Abraham Anderson Selected Research

Abraham Anderson Research Topics

7	Neoplasms (Cancer) 01/2021 - 01/2010
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 04/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2016
2	Bites and Stings (Sting) 01/2021 - 04/2020
2	Fatigue 09/2011 - 05/2010
2	Nausea 09/2011 - 05/2010
1	Philadelphia Chromosome 01/2021
1	Residual Neoplasm 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2017
1	Neoplasm Metastasis (Metastasis) 08/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2014
1	Neutropenia 08/2014
1	Venous Thromboembolism 08/2014
1	Adenocarcinoma 08/2014
1	Thrombocytopenia (Thrombopenia) 08/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2011
1	Gliosarcoma 04/2011
1	Glioblastoma (Glioblastoma Multiforme) 04/2011
1	Cholecystitis 05/2010
1	Constipation 05/2010
1	Edema (Dropsy) 05/2010

5	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2014 - 01/2010
5	rilotumumabIBA 08/2014 - 01/2010
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
4	Monoclonal AntibodiesIBA 09/2011 - 01/2010
3	blinatumomabIBA 01/2021 - 04/2020
2	talimogene laherparepvecIBA 01/2021 - 01/2016
1	sotorasibIBA 01/2021
1	AntigensIBA 01/2021
1	N- (4- ((3- (2- amino- 4- pyrimidinyl)- 2- pyridinyl)oxy)phenyl)- 4- (4- methyl- 2- thienyl)- 1- phthalazinamineIBA 07/2017
1	Aurora KinasesIBA 07/2017
1	CTLA-4 AntigenIBA 01/2016
1	IpilimumabIBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 08/2014
1	Epirubicin (Ellence)FDA LinkGeneric 08/2014
1	Capecitabine (Xeloda)FDA Link 08/2014
1	Dihydrotachysterol (AT 10)IBA 09/2011
1	motesanib diphosphateIBA 05/2010
1	Bevacizumab (Avastin)FDA Link 05/2010

5	Therapeutics 01/2022 - 04/2011
1	Drug Therapy (Chemotherapy) 01/2021